Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Manchanda, Ranjit; Patel, Shreeya; Gordeev, Vladimir S; Antoniou, Antonis C; Smith, Shantel; Lee, Andrew; Hopper, John L; MacInnis, Robert J; Turnbull, Clare; Ramus, Susan J; +5 more... Gayther, Simon A; Pharoah, Paul DP; Menon, Usha; Jacobs, Ian; Legood, Rosa; (2018) Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. Journal of the National Cancer Institute, 110 (7). pp. 714-725. ISSN 0027-8874 DOI: https://doi.org/10.1093/jnci/djx265

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/jnci/djx265

Abstract

Share

Download

Filename: Cost-effectiveness of population_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar